https://www.uea.ac.uk/medicine/departments/psychological-sciences/cognitive-behavioural-therapy-training/-about-iapt-and-the-history-of-the-programme/stepped-care-model-information
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3283464/
https://www.lenus.ie/bitstream/handle/10147/250780/Asteppedcareapproach.pdf?sequence=1&isAllowed=y
https://www.psychology.org.au/for-members/publications/inpsych/2018/December-Issue-6/Stepped-care-for-mental-health-treatment-A-system
https://pdfs.semanticscholar.org/1e77/aa133e9ec168d4cc674afb7ce65258cb0e07.pdf
https://jamanetwork.com/journals/jamapsychiatry/fullarticle/482992
https://wellbeinginfo.org/self-help/mental-health/stepped-care/
Thursday, September 12, 2019
Wednesday, September 11, 2019
決定不要去開會之後
這幾天埋在 NPS 中起因是 Fentanyl Inc. (Ben Westhoff, 2019) 原本的理解只限於 OxyContin 到
Fetanyl 這條線但顯然這條線和 NPS 是纏在一起發生的
Fetanyl Analogues 屬於 NPS 的大家族而中國在 NPS 以至 Fetanyl analogues 的角色正是無良山寨世界工廠 Westhoff 說這是一千億美元的大生意中國盆滿缽滿之餘順便鴉片戰爭惡搞老美所以這是生意也是超限戰的下流操作治療上能說的仍止於一般通俗的說法對 Fetanyl analogues 也許有用但對成分組合複雜的那亂混一鍋的 NPS 則徹底無知比如說 The ASAM Principles of Addiction Medicine (2018) 關於 NPS 僅只短短數頁就算一章這件事的危險在你不知道你吞了吸了注射了甚麼鬼名堂但你以為你用了 designer drug 就算是一個 designed self
Youth Substance Abuse: A Reference Handbook (Contemporary World Issues) (David E. Newton, ABC-CLIO, 2016)
This text provides readers with an in-depth understanding of the essential aspects of youth substance abuse―an important contemporary personal, social, and public health issue.
• Presents individual perspectives on youth substance abuse issues that provide readers with a very personal outlook on specific aspects of the topic
• Provides readers with broad coverage of current issues and topics in substance abuse by adolescents as well as a historical perspective of how this problem has developed in the United States over the past century
• Includes a chapter of primary documents sourced from a number of laws and court cases dealing with various aspects of youth substance abuse (amazon)
Semisynthetic and synthetic opioids
https://en.wikipedia.org/wiki/Opioid#Semisynthetic_and_synthetic_opioids
Synthetic opioids were invented, and biological mechanisms for their actions discovered, in the 20th century.[167] Scientists have searched for non-addictive forms of opioids, but have created stronger ones instead. In England Charles Romley Alder Wright developed hundreds of opiate compounds in his search for a nonaddictive opium derivative. In 1874 he became the first person to synthesize diamorphine (heroin), using a process called acetylation which involvedboiling morphine with acetic anhydride for several hours.[179]
Heroin received little attention until it was independently synthesized by Felix Hoffmann (1868–1946), working for Heinrich Dreser (1860–1924) at Bayer Laboratories.[193] Dreser brought the new drug to market as an analgesic and a cough treatment for tuberculosis, bronchitis, and asthma in 1898. Bayer ceased production in 1913, after heroin's addictive potential was recognized.[179][194][195]
Several semi-synthetic opioids were developed in Germany in the 1910s. The first, oxymorphone, was synthesized from thebaine, an opioid alkaloid in opium poppies, in 1914.[196] Next, Martin Freund and Edmund Speyer developed oxycodone, also from thebaine, at the University of Frankfurt in 1916.[197] In 1920, hydrocodone was prepared by Carl Mannich and Helene Löwenheim, deriving it from codeine. In 1924, hydromorphone was synthesized by adding hydrogen to morphine. Etorphine was synthesized in 1960, from the oripavine in opium poppy straw. Buprenorphine was discovered in 1972.[196]
The first fully synthetic opioid was meperidine (later demerol), found serendipitously by German chemist Otto Eisleb (or Eislib) at IG Farben in 1932.[196] Meperidine was the first opiate to have a structure unrelated to morphine, but with opiate-like properties.[167] Its analgesis effects were discovered by Otto Schaumann in 1939.[196] Gustav Ehrhart and Max Bockmühl, also at IG Farben, built on the work of Eisleb and Schaumann. They developed "Hoechst 10820" (later methadone) around 1937.[198] In 1959 the Belgian physician Paul Janssen developed fentanyl, a synthetic drug with 30 to 50 times the potency of heroin.[179][199] Nearly 150 synthetic opioids are now known.[196]
List of fentanyl analogues
https://en.wikipedia.org/wiki/List_of_fentanyl_analogues
This is not a comprehensive listing of fentanyl analogues, as more than 1400 compounds from this family have been described in the scientific and patent literature,[6][7] but it includes all notable compounds that have reached late-stage human clinical trials, or which have been identified as having been sold as designer drugs.
This is not a comprehensive listing of fentanyl analogues, as more than 1400 compounds from this family have been described in the scientific and patent literature,[6][7] but it includes all notable compounds that have reached late-stage human clinical trials, or which have been identified as having been sold as designer drugs.
Tuesday, September 10, 2019
Drugs Unlimited: The Web Revolution That's Changing How the World Gets High (Mike Power, Thomas Dunne Books, 2014)
The very first thing ever bought or sold on the Internet was marijuana, when Stanford and MIT students used ARPANET to cut a deal in the early '70s. Today, you can order any conceivable pill or powder with the click of a mouse. In Drugs Unlimited, Mike Power tells the tale of drugs in the Internet Age, in which users have outmaneuvered law enforcement, breached international borders, and created a massive worldwide black market.
But the online market in narcotics isn't just changing the way drugs are bought and sold; it's changing the nature of drugs themselves. Enterprising dealers are using the Web to engage highly skilled foreign chemists to tweak the chemical structures of banned drugs―just enough to create a similar effect and just enough to render them legal in most parts of the world. Drugs are marketed as "not for human consumption," but everyone knows exactly how they're going to be used―what they can't know is whether their use might prove fatal.
From dancefloors to the offices of apathetic government officials, via social networking sites and underground labs, Power explores this agile, international, virtual subculture that will always be one step ahead of the law. (amazon) (accessible via scribd)
Is Xi Mishandling Hong Kong Crisis? Hints of Unease in China’s Leadership (Steven Lee Myers, Chris Buckley and Keith Bradsher, NYT, 2019-9-9)
https://www.youtube.com/watch?v=_fd3nntljW8
https://www.nytimes.com/2019/09/07/world/asia/china-hong-kong-xi-jinping.html
https://cn.nytimes.com/china/20190909/china-hong-kong-xi-jinping/zh-hant/
https://www.nytimes.com/2019/09/07/world/asia/china-hong-kong-xi-jinping.html
https://cn.nytimes.com/china/20190909/china-hong-kong-xi-jinping/zh-hant/
Trump Agriculture Trade Official Calls Xi ‘Communist Zealot’ (Mike Dorning, Bloomberg, 2019-9-10)
https://www.youtube.com/watch?v=Gw8mCo4UkGs
https://www.bloomberg.com/news/articles/2019-09-09/trump-agriculture-trade-official-calls-xi-communist-zealot
https://ec.ltn.com.tw/article/breakingnews/2911036
https://www.bloomberg.com/news/articles/2019-09-09/trump-agriculture-trade-official-calls-xi-communist-zealot
https://ec.ltn.com.tw/article/breakingnews/2911036
Monday, September 9, 2019
第八天
https://www.youtube.com/watch?v=KCrO3sKfL5s
these days, worn out, sweaty, bloody, rarely carefree, not to mention soothing; wondering 解放軍進城的時候, 韓國瑜郭台銘會躲在誰的床下, 那明顯必須是一張大床, 否則塞不下這兩尾出來混遲早要還的冒牌貨; 怎麼分辨誰是地下黨, 這是一個超過台灣網民智商和歷史判斷的問題;
these days, worn out, sweaty, bloody, rarely carefree, not to mention soothing; wondering 解放軍進城的時候, 韓國瑜郭台銘會躲在誰的床下, 那明顯必須是一張大床, 否則塞不下這兩尾出來混遲早要還的冒牌貨; 怎麼分辨誰是地下黨, 這是一個超過台灣網民智商和歷史判斷的問題;
习近平下台是党內共识 ？习很冲动要斗争，党內谁是敌人？王岐山误导习，強硬对待一切，四面皆敌（何频 陶杰 张洵 马聚 李恒青 邓聿文：20190909）
https://www.youtube.com/watch?v=MrgJQbkLYsc
鬥爭鬥爭鬥爭鬥爭鬥爭鬥爭鬥爭鬥爭鬥爭鬥爭鬥爭鬥爭鬥爭鬥爭鬥爭鬥爭鬥爭鬥爭鬥爭鬥爭鬥爭鬥爭鬥爭鬥爭鬥爭鬥爭鬥爭鬥爭鬥爭鬥爭鬥爭鬥爭鬥爭鬥爭鬥爭鬥爭鬥爭鬥爭鬥爭鬥爭鬥爭鬥爭鬥爭鬥爭鬥爭鬥爭鬥爭鬥爭鬥爭鬥爭鬥爭鬥爭鬥爭鬥爭鬥爭鬥爭鬥爭鬥爭
凡是凡是凡是凡是凡是
designer drugs
https://en.wikipedia.org/wiki/List_of_designer_drugs
https://en.wikipedia.org/wiki/Designer_drug#List
https://www.dea.gov/es/taxonomy/term/341
https://www.therecoveryvillage.com/drug-addiction/designer-drugs/#gref
https://novarecoverycenter.com/trending-street-drugs/what-are-designer-drugs/
https://en.wikipedia.org/wiki/Designer_drug#List
https://www.dea.gov/es/taxonomy/term/341
https://www.therecoveryvillage.com/drug-addiction/designer-drugs/#gref
https://novarecoverycenter.com/trending-street-drugs/what-are-designer-drugs/
Designer drugs: past history and future prospects (Gary Henderson, 1988)
https://www.ncbi.nlm.nih.gov/pubmed/3286815
J Forensic Sci. 1988 Mar;33(2):569-75.
see also
J Forensic Sci. 1988 Mar;33(2):569-75.
Abstract
Historically, drugs of abuse have come from two sources: plant products and diverted pharmaceuticals. Today, new, totally synthetic drugs produced by clandestine laboratories have become an increasingly important source of abused substances. Of particular concern are the fentanyls, a family of very potent narcotic analgesics, which first appeared on the streets in California in 1979 under the name "China White". At least 10 different analogs have been identified to date and are thought to be responsible for over 100 overdose deaths. The fentanyls are not used by any particular ethic or age group, but rather by the general heroin using population. Their use, however, does seem to be restricted to suburban, rather than urban areas, and almost exclusively to the state of California. The most potent analogs, the 3-methyl- and beta-hydroxy-fentanyls, may be up to 1000 times as potent as heroin, but are not chemically related to the opiates and therefore not detected by conventional narcotic screening tests. However, using a sensitive radioimmunoassay highly specific for the fentanyls they can be measured at the very low concentrations observed in body fluids, generally less than 10 ng/mL. It is likely that, as efforts to restrict the importation of natural products and prevent diversion of pharmaceuticals become more effective, the fentanyls and other synthetics will become increasingly important drugs of abuse.
see also
In the mid-1980s, it wasn’t clear whether these types of “synthetic heroin” would become a plague or simply fade away. A University of California at Davis pharmacology professor named Gary Henderson studied the chemical impurities in China White and concluded that a single chemist was responsible for all of it. “Most likely he made a few grams of the drug—millions of doses—and then shut up his shop,” he told journalist Jack Shafer in 1985.
Henderson became the scientist doctors turned to when their overdose patients had strange blood samples, and the DEA consulted when it turned up inscrutable chemicals. He had already been researching fentanyl for years; his lab focused on how it was used to dope racehorses, whose urine turned up traces of it. He worked to develop a technique to identify fentanyl and began to understand the nature of the drug, including its potential for chemical manipulation. “Perhaps hundreds,” he said, when asked how many fentanyl analogues would be possible. “Maybe thousands.”
Henderson was way ahead of his time when it came to predicting the horrors not just of fentanyl but of NPS generally. “It seems we are still watching reruns of The French Connection while there is someone out there using a computer to search the chemical literature looking for new drugs to synthesize,” he told the US Senate’s Budget Committee in July 1985, a statement that was remarkably prescient. He coined the phrase designer drugs, defining them as “substances where the psychoactive properties of a drug are retained, but the molecular structure has been altered to avoid prosecution.” Often synthesized from common chemicals, they were skillfully marketed under attractive, exotic names, he added. His 1988 paper “Designer Drugs: Past History and Future Prospects” is nothing less than prophecy, speculating accurately not just on the future of NPS chemistry but on the implications for law enforcement. “In the view of this author,” he wrote, “it is likely that the future drugs of abuse will be synthetics rather than plant products. A single gram of any very potent drug could be synthesized at one location, transported to distribution sites worldwide, and then formulated (cut) into many thousand, perhaps a million, doses…. Preventing the distribution of such small amounts of the pure drug will be exceedingly difficult…. In fact, any success we may have in curtailing the distribution of natural products such as opium, coca, and marijuana and preventing the diversion of pharmaceuticals will only stimulate the development of potent synthetic substitutes.”
Westhoff, Ben. Fentanyl, Inc. (Kindle location 654-674/6750). Grove Atlantic. 2019, Kindle edition.
a view from somewhere
Therefore, hermeneuticists conclude that when researchers claim to bracket off their prejudgements, they only succeed in disguising them. For this reason, critics of scientism have called it “a view from nowhere” — meaning that its values and commitments are nowhere to be seen. Our only hope, hermeneuticists such as Heidegger argued, is to develop ways of thinking about human being that understand that people are on-going events, not static things that can be known, controlled, and repaired through the use of technicist, instrumental methods. Without such understanding, we are continually involved in a self-deception about the content and limits of human knowledge. Historically, some of our most damaging social problems can be traced to beliefs and actions justified by the warrant of objectivity. (pp. 211-13)
Cushman, P. (2013). Because the Rock Will not Read the Article: A Discussion of Jeremy D. Safran's Critique of Irwin Z. Hoffman's “Doublethinking our way to Scientific Legitimacy”. Psychoanal. Dial., 23(2):211-224
Therefore, the following:
a view from somewhere - hermeneutics
a view from nowhere - scientism
a view from anywhere - The Big Brother
and, nowhere is anywhere
Cushman, P. (2013). Because the Rock Will not Read the Article: A Discussion of Jeremy D. Safran's Critique of Irwin Z. Hoffman's “Doublethinking our way to Scientific Legitimacy”. Psychoanal. Dial., 23(2):211-224
Therefore, the following:
a view from somewhere - hermeneutics
a view from nowhere - scientism
a view from anywhere - The Big Brother
and, nowhere is anywhere
《习近平与他的情人们》一书在洛杉矶出版 (2019-6-26)
https://www.rfa.org/mandarin/yataibaodao/zhengzhi/ck-06262019091902.html
https://news.ltn.com.tw/news/world/breakingnews/2838005
http://blog.creaders.net/u/16885/201906/352468.html
https://www.bannedbook.org/bnews/zh-tw/tag/%E3%80%8A%E4%B9%A0%E8%BF%91%E5%B9%B3%E4%B8%8E%E4%BB%96%E7%9A%84%E6%83%85%E4%BA%BA%E4%BB%AC%E3%80%8B/
https://www.molihua.org/2016/02/blog-post_74.html
http://news.memehk.com/posts/13947
https://books.google.com.hk/books?id=cDx_CwAAQBAJ&pg=PA37&lpg=PA37&dq=%E8%A5%BF%E8%AB%BE+%E7%BF%92%E8%BF%91%E5%B9%B3&source=bl&ots=mVC8dYqVvR&sig=CT0SRaYEOeJ-qwtdzTFD67J7UFI&hl=en&sa=X&ved=0ahUKEwiRzcTQvt_KAhVKHZQKHYFjC4kQ6AEIQTAG#v=onepage&q=%E8%A5%BF%E8%AB%BE%20%E7%BF%92%E8%BF%91%E5%B9%B3&f=false
https://news.ltn.com.tw/news/world/breakingnews/2838005
http://blog.creaders.net/u/16885/201906/352468.html
https://www.bannedbook.org/bnews/zh-tw/tag/%E3%80%8A%E4%B9%A0%E8%BF%91%E5%B9%B3%E4%B8%8E%E4%BB%96%E7%9A%84%E6%83%85%E4%BA%BA%E4%BB%AC%E3%80%8B/
https://www.molihua.org/2016/02/blog-post_74.html
http://news.memehk.com/posts/13947
https://books.google.com.hk/books?id=cDx_CwAAQBAJ&pg=PA37&lpg=PA37&dq=%E8%A5%BF%E8%AB%BE+%E7%BF%92%E8%BF%91%E5%B9%B3&source=bl&ots=mVC8dYqVvR&sig=CT0SRaYEOeJ-qwtdzTFD67J7UFI&hl=en&sa=X&ved=0ahUKEwiRzcTQvt_KAhVKHZQKHYFjC4kQ6AEIQTAG#v=onepage&q=%E8%A5%BF%E8%AB%BE%20%E7%BF%92%E8%BF%91%E5%B9%B3&f=false
Sunday, September 8, 2019
Handbook of Novel Psychoactive Substances: What Clinicians Should Know about NPS (ed. Ornella Corazza, Andres Roman-Urrestarazu, Routledge, 2018)
Handbook of Novel Psychoactive Substances (NPS) provides a comprehensive overview of the challenges that clinicians face when dealing with NPS and discusses how the profile of patients and their socio-demographic characteristics frame the serious public health concern that NPS pose. It presents various clinical cases, as well as detailed accounts of symptoms, psychopathology, toxicity, and overall clinical management that NPS require. This handbook brings together a unique collection of chapters written by leading experts in the field, who have felt the need to share their knowledge and experience to improve the clinical practice on NPS and the wellbeing of their patients. (amazon) (kindle 2019-10-23)
Novel Psychoactive Substances: Classification, Pharmacology and Toxicology (ed. Paul Dargan, David Wood, Academic Press, 2013)
Novel Psychoactive Substances: Classification, Pharmacology and Toxicology provides readers with background on the classification, detection, supply and availability of novel psychoactive substances, otherwise known as "legal highs." This book also covers individual classes of novel psychoactive substances that have recently emerged onto the recreational drug scene and provides an overview of the pharmacology of the substance followed by a discussion of the acute and chronic harm or toxicity associated with the substance. Written by international experts in the field, this multi-authored book is a valuable reference for scientists, clinicians, academics, and regulatory and law enforcement professionals.
- Includes chapters written by international experts in the field.
- Provides a comprehensive look at the classification, detection, availability and supply of novel psychoactive substances, in addition to the pharmacology and toxicology associated with the substance.
- Offers a single source for all interested parties working in this area, including scientists, academics, clinicians, law enforcement and regulatory agencies.
- Provides a full treatment of novel psychoactive substances that have recently emerged onto the recreational drug scene including mephedrone and the synthetic cannabinoid receptors in ‘spice’ / ‘K2’. (amazon) (accessible via scribd)
Recent Changes in Drug Abuse Scenario The Novel Psychoactive Substances (NPS) Phenomenon (ed. Fabrizio Schifano, Mdpi AG, 2019-1-15)
In parallel with a decrease/stabilization in the use of internationally controlled drugs, the market of novel psychoactive substances (NPS) continues increasing, year after year, with the Internet playing a pivotal role in contributing to this complex scenario. At times, although misleading, the terms 'legal highs' or 'research chemicals' have been used to describe these molecules. Overall, about 5% of 19-24-year-old European people have already experimented with them, because both NPS' intense psychoactive effects and their virtual non-detectability in routine drug screenings. Although 'novel' typically refers to molecules that have recently become a reason of current/potential public health concern, at times, the NPS scenario may indeed focus on pharmaceutical molecules. These may have either not entered the market, or are currently prescribed, with their potential for misuse resulting from the relating high dosages/idiosyncratic ways of self-administration. A concurrent use of a range of different NPS, and/or medications, is frequently being reported and this may be a reason of further clinical complications. Given their complex pharmacodynamics, there are increasing levels of concern about the onset of acute/chronic psychopathological associated with NPS intake. This Special Issue aims at providing an overview of a range of NPS-related issues, e.g., preclinical, epidemiological, and clinical pharmacological; the medical and psychopathological consequences associated with their intake; and, finally, the analytical chemistry and forensic analysis challenges associated with the NPS phenomenon. (amazon)
NPS
Novel psychoactive substances: types, mechanisms of action, and effects, BMJ 2017;356:i6848
https://www.bmj.com/content/356/bmj.i6848
What you need to know
- Novel psychoactive substances (NPS, “legal highs”) are compounds designed to mimic existing established recreational drugs. They can be grouped into four main categories: stimulants, cannabinoids, hallucinogens, and depressants
- Legislation regarding NPS varies internationally. In the UK it is now illegal to distribute or sell NPS, but possession is not a criminal offence
- NPS should not be regarded as safer than established recreational drugs
- The most commonly clinically encountered NPS are stimulants (such as mephedrone) and cannabinoids (such as “spice”)
- Psychiatric and rehabilitation units, prisons, and schools face particular challenges in detecting and preventing use
In 2016 the Psychoactive Substances Bill banned trading but not possession of all current and future novel psychoactive substances (NPS), sometimes incorrectly called “legal highs,” in an attempt to overcome rapid proliferation of these compounds. Over 560 substances are currently monitored by the European Monitoring Centre for Drugs and Drug Addiction, with 100 new agents identified in 2015 alone. Stimulants and synthetic cannabinoids account for the vast majority and are the types most commonly clinically encountered.1 Online purchases are increasing according to the 2016 Global Drug Survey,2 potentially in response to legislative changes, as is overall NPS use: lifetime consumption was reported by 8% of younger individuals in 2015, up from 5% in 2011, with figures relatively similar between sexes and different countries.3
Heijin: Organized Crime, Business, and Politics in Taiwan (Taiwan in the Modern World) (Ko-Lin Chin, Routledge, 2003)
This work examines the structure and illegal activities of organized crime groups in Taiwan and explores the infiltration of crime groups into the business and political arenas. It looks at the intricate relationship among government officials, elected deputies, businessmen, and underworld figures. (amazon)
Drug Dealer, MD: How Doctors Were Duped, Patients Got Hooked, and Why It’s So Hard to Stop (Anna Lembke, Johns Hopkins University Press, 2016)
Three out of four people addicted to heroin probably started on a prescription opioid, according to the director of the Centers for Disease Control and Prevention. In the United States alone, 16,000 people die each year as a result of prescription opioid overdose. But perhaps the most frightening aspect of the prescription drug epidemic is that it’s built on well-meaning doctors treating patients with real problems.
In Drug Dealer, MD, Dr. Anna Lembke uncovers the unseen forces driving opioid addiction nationwide. Combining case studies from her own practice with vital statistics drawn from public policy, cultural anthropology, and neuroscience, she explores the complex relationship between doctors and patients, the science of addiction, and the barriers to successfully addressing drug dependence and addiction. Even when addiction is recognized by doctors and their patients, she argues, many doctors don’t know how to treat it, connections to treatment are lacking, and insurance companies won’t pay for rehab.
Full of extensive interviews―with health care providers, pharmacists, social workers, hospital administrators, insurance company executives, journalists, economists, advocates, and patients and their families―Drug Dealer, MD, is for anyone whose life has been touched in some way by addiction to prescription drugs. Dr. Lembke gives voice to the millions of Americans struggling with prescription drugs while singling out the real culprits behind the rise in opioid addiction: cultural narratives that promote pills as quick fixes, pharmaceutical corporations in cahoots with organized medicine, and a new medical bureaucracy focused on the bottom line that favors pills, procedures, and patient satisfaction over wellness. Dr. Lembke concludes that the prescription drug epidemic is a symptom of a faltering health care system, the solution for which lies in rethinking how health care is delivered. (amazon)
The Chinese Heroin Trade: Cross-Border Drug Trafficking in Southeast Asia and Beyond (Ko-lin Chin, Sheldon X. Zhang, NYU Press, 2015)
In a country long associated with the trade in opiates, the Chinese government has for decades applied extreme measures to curtail the spread of illicit drugs, only to find that the problem has worsened. Burma is blamed as the major producer of illicit drugs and conduit for the entry of drugs into China. Which organizations are behind the heroin trade? What problems and prospects of drug control in the so-called “Golden Triangle” drug-trafficking region are faced by Chinese and Southeast Asian authorities?
In The Chinese Heroin Trade, noted criminologists Ko-Lin Chin and Sheldon Zhangexamine the social organization of the trafficking of heroin from the Golden Triangle to China and the wholesale and retail distribution of the drug in China. Based on face-to-face interviews with hundreds of incarcerated drug traffickers, street-level drug dealers, users, and authorities, paired with extensive fieldwork in the border areas of Burma and China and several major urban centers in China and Southeast Asia, this volume reveals how the drug trade has evolved in the Golden Triangle since the late 1980s. Chin and Zhang also explore the marked characteristics of heroin traffickers; the relationship between drug use and sales in China; and how China compares to other international drug markets. The Chinese Heroin Trade is a fascinating, nuanced account of the world of high-risk drug trafficking in a tightly-controlled society. (amazon)
see also
https://www.brookings.edu/wp-content/uploads/2016/07/A-Peoples-War-final.pdf
see also
https://www.brookings.edu/wp-content/uploads/2016/07/A-Peoples-War-final.pdf
Sidney Rittenberg obituary (The Guardian, 2019-8-28)
https://www.theguardian.com/world/2019/aug/28/sidney-rittenberg-obituary
Rittenberg explained that his idealism and the belief that he was taking part in the development of a new and better world blinded him to the atrocious persecution and murder of even close friends of his. “It’s a kind of corruption, exactly the kind of corruption that ruins the whole thing,” he said. “I believed I was part of history. That’s what you get with ideology and power. You learn to harden your heart in the name of the wonderful new world you’re building. Once you do that, you do all kinds of things. I did.”
革完別人的命之後 他變成一隻大熊貓
繼續義正詞嚴
Disillusioned with communism, he returned to the US in 1980 with his wife and their four children.
There, he founded Rittenberg Associates, a consulting company that helped businesses from Colgate Palmolive to Warner Music to Intel, Microsoft and PricewaterhouseCoopers to establish themselves in China. (i.e. even revolutionaries need to do businesses, which, of course, are revolutionary businesses)
“I think China has to face the fact that Mao was one of the worst people in human history,” was Rittenberg’s assessment of Mao in old age. “He was a genius, but his genius got completely out of control, so he was a great historic leader and a great historic criminal. He gave himself the right to conduct social experiments that involved upturning the lives of hundreds of millions of people, when he didn’t know what the outcome might be. And that created famines in which tens of millions died, and a revolution in which nobody knows how many died.” Rittenberg explained that his idealism and the belief that he was taking part in the development of a new and better world blinded him to the atrocious persecution and murder of even close friends of his. “It’s a kind of corruption, exactly the kind of corruption that ruins the whole thing,” he said. “I believed I was part of history. That’s what you get with ideology and power. You learn to harden your heart in the name of the wonderful new world you’re building. Once you do that, you do all kinds of things. I did.”
Saturday, September 7, 2019
醫院消息：6人遭斷頸亡
https://www.youtube.com/watch?v=59djgfHHVIk&t=240s
又添冤魂 港警殺人 但極可能是中共武警假冒之港警所為 真港警應出面澄清真相 這件事說明中共的邪惡
和反共必須血債血償 那過去七十年被屠殺的八千萬人 應化為八千萬厲鬼 要這九千萬黨員償命
大陸貧富差距為世界之最 恐造成社會動盪 (2016-1-18)
http://www.epochtimes.com/b5/16/1/18/n4619672.htm
北京大學的一份調查報告顯示，中國社會不平等趨勢擴大，1%的家庭占有全國三分之一的財產，底端25%的家庭擁有的財產總量僅1%左右。北京理工大學教授胡星斗在美國之音連線節目中警告，中國貧富差距過大的現象嚴重，基尼係數超過0.6接近社會動亂。
Novel Antidepressant Reduces Depression Symptoms in 2 Weeks (NEJM Journal Watch, 2019--9-5)
https://www.jwatch.org/fw115787/2019/09/05/novel-antidepressant-reduces-depression-symptoms-2-weeks?query=pfwRSTOC&jwd=000013567342&jspc=P
SAGE-217, is an oral positive allosteric modulator of γ-aminobutyric acid (GABA) type A receptors
SAGE-217, is an oral positive allosteric modulator of γ-aminobutyric acid (GABA) type A receptors
Friday, September 6, 2019
神秘錄音流出 疑似官員洩露
https://www.youtube.com/watch?v=GG22zzTrfvc
https://tw.aboluowang.com/2019/0905/1338890.html
https://tw.aboluowang.com/2019/0905/1338890.html
“你提的這個出口加稅的問題呀，我是這樣理解的，美國一加稅，我們左邊加了稅錢，右邊增加流動性、印鈔，還有退稅，用各種辦法還可以補回來，兩邊一個左手、一個右手，問題不是太大。
“但最大的問題是，美國一加稅，在中國的外資企業就待不住了，他們何必要交這25%的稅呢，他們要賺錢嘛，所以他們就要把企業遷走，遷到越南，遷到泰國，他們不是要將利潤做到最大化嗎？
“外資撤走了，我們在外資工作的員工大概有4,500萬人，這些人可就失業了。國有企業安排不了這麼大一塊兒就業人口，再加上中國出口加工貿易企業，也會完的，所以這還有幾千萬人，可能有8,000多萬人失業沒有工作，這些人都供著房（貸款買房）呢，你想一想會給中國帶來什麼問題？
“就業的問題，其實背後牽扯的是金融的危機、地產的危機，這兩個危機是統治階級——統治的危機。所以經濟硬著陸會帶來中國巨大的變化，這個才是最關鍵的。
“原來管證監會的劉士余，現在干供銷總社的社長，他在全國各省建立供銷社，供銷社是我們改革開放基本消失了的遺產，現在都在恢復。建立供銷社最大的意圖就是要搞統購統銷。
“其實高層早就做好了這個準備了，用統購統銷的計劃經濟、票證經濟，來管理現在不斷衰弱和硬著陸以後的中國經濟，你說經濟結構是不是要變？要徹底地變回到計劃經濟了，你那時候再搞個體創業，都沒的創了。
“還有一個就是，到萬不得已的時候可能要發行新的貨幣，要銀行把原來的舊幣收回，這樣很多人藏在床底下的錢都得拿出來，不然就作廢了。用這種辦法可以把地下的很多資金全部洗出來，來解決現在錢不夠的問題。這些辦法都會用，所以大家早做準備吧。
“很多人都在拚命地撈錢，其實他們都沒有弄明白，錢是什麼？錢是政府給人民發的條子，這個東西呀，政府要認，它就能用，政府不認了，從新換另外的條子，那別的就都沒用了。所以看上去你撈了很多錢，其實到時候政府一不認，換新鈔票其它全都廢了。
“所以，錢並不是真正的財富，你把錢變成其它的商品或者外匯、黃金，那才是財富呢。
“老百姓的財富，其實是政府的負債，政府要想消減自己的負債，它可以用蒸發股市的辦法解決，也可以用蒸發樓市的辦法解決。
“我給大家講的兩個概念，一個是鈔票啊、人民幣啊，這都是條子，不是財富；第二個是老百姓的財富是什麼，是政府的負債，你不要以為你的東西都是你的，政府想拿過來分分鐘，想搞定你也分分鐘。所以說土財主、近視眼是看不懂的，你看王健林，轉眼就讓你完蛋。
“所以明白了這個道理，你才知道什麼叫財富。真正的財富是掌控在自己手裡，而且能夠升值、保值，並且具有流動性的好東西才是財富。好多人玩兒了半天都沒弄明白這一點。
“我在三年前就跟很多朋友講了，你們要做好過苦日子的準備了，因為要走計劃經濟了，真的走向計劃經濟的時候，個體工商、民營資產全部都要搞掉了，計劃經濟不可能允許你亂搞計劃之外的事情，共產黨把所有的財路都攬去了，你們再想掙錢是不可能了。所有早一點想想該怎麼活，這才是要緊的事情。
“再一個就是，能出去的就出去吧，不要到美國去，將來那裡是敵國，你到那邊財產都要被沒收的，找一個中間的地方去，財產拿出去以後，你乾脆就把戶籍也消了，你還是中國戶口，你的錢在外邊你還得在國內要交稅。所以真正的財富是不被政府所知道的東西，才是屬於你的財富。
“另外，考慮財富的問題現在已經來不及了，下一步就是考慮我們的生存的問題了。
“估計到下半年人民幣就要開始貶值了，用貨幣貶值來對付美國，這是第一個；第二個，我們從去年到今年，非洲豬瘟（蔓延）這麼多省，今年下半年豬瘟會越來越厲害，加上進口（豬肉）也有困難了，豬肉會很貴，豬肉帶動整個CPI（中國居民消費價格指數）的上升，大家都會感覺到通貨膨脹轉眼到身邊了，錢不好用了，將來吃什麼東西也是個問題，可能會帶來很多新的認識。
“再有一個就是，我們現在所做的所有事情，都不可能改變中國現在的根本狀況，因為（中共）高層還在激烈的鬥爭，鬥爭會越演越烈，將來究竟花落誰手，這麼的一個攤子，誰來接都說不定。所以老百姓是顧及不過來的，看不到這個大盤的反應。
“我估計，下周連美國股市的指數也可能會跌，因為帶來的變化是巨大的。美國已經開始考慮另外3,250億美元商品25%的關稅了，如果中國（中共）出台比較強硬的反制措施的話，美國就會把中國定為匯率操縱國，這樣就不是25%的關稅了，就要上升到40%到45%了，到那時候就徹底斷交了，那我們就重新回到毛時代了。
“現在是（中共高層）三個勢力在鬥爭，當然也有不走計劃經濟的力量，但是能不能成氣候還不一定，現在討論哪一路上台，這對我們很危險，所以不去議論這事。
“現在很多開放措施是做給美國人看的，它是配合中美貿易談判的。其實談判成功了，這些措施不一定照著辦了，中國人什麼時候有誠信啊，你還以為政府發了文件了就照著辦了，沒有那事情……”
錄音談話的時間點或在今年5月，美國政府發布計劃對3250億美元中國商品加征25%關稅的公告之前。
72 foretold
9/6 6:24 AM, cool, humid, s/p raining all night; forensic report done; ICF not done yet; bill forms to be sent; noon discussion MMT troublemaker, 碰到問題 解決問題 不要責備 (以後再提增人手); next monday discussion, back to H2, keep A7?; 人事異動之際 易亂; 9/7 3:14 PM, one ER this morning, Parkinson's disease with L-dopa-induced psychosis; then around noon, H2, one pt 要求外出驗傷; H3 one elderly pt, agitated; another middle-aged pt, fidgety;平淡的說 平淡的事 我是洗碗工 這是血汗工廠; 7:00 PM, H2 one agitated; 9/9 11:00 AM, one ER, lab pending, waiting for adm; 1:20 PM adm; 2 consults CM;
Thursday, September 5, 2019
Wednesday, September 4, 2019
Tuesday, September 3, 2019
failed artist (artiste manque)
Using an idea from Schopenhauer, Rank develops a metaphor: Life is
a loan, death the repayment. The artist type takes the loan and spends or invests
it—willingly. Such a person accepts the finite term of the loan, and makes choices in accordance with that reality. The neurotic,
in contrast, cannot willingly accept the loan with its limit. He or she
vacillates, paralyzed by anxiety and doubt, refusing to commit the
life-loan. At repayment time, the neurotic hopes—pathetically—to flout the
limit. “I haven’t begun yet. I should not have to die—I have not
really lived!”
Subscribe to:
Posts (Atom)